Form 4: Curis Inc. CFO Diantha Duvall Reports Stock Option Grant

Diantha Duvall, CFO of Curis Inc., reports the grant of a stock option for 39,000 shares following shareholder approval of the Fifth Amended and Restated 2010 Stock Incentive Plan.

Summary

• Diantha Duvall, CFO of Curis Inc., filed a Form 4 on May 23, 2024, reporting a transaction.
• The transaction involves the grant of an employee stock option (right to buy) 39,000 shares of Curis Inc. common stock.
• The exercise price of the option is $11.62 per share.
• The option was granted on May 21, 2024, and expires on January 18, 2034.
• The option vests as to 25% of the original shares on January 19, 2025, and then 6.25% each quarter until January 19, 2028.
• The grant was contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan, which was obtained on May 21, 2024.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant, which is generally neutral. The shareholder approval of the stock incentive plan is a slightly positive sign.

Positives

• The grant of stock options to the CFO aligns her interests with those of the shareholders.
• Shareholder approval of the Fifth Amended and Restated 2010 Stock Incentive Plan enables the company to grant equity-based compensation.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the option.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options, are common in the biotech industry to attract and retain talent.
• The vesting schedule of the options is fairly standard, with a multi-year vesting period to incentivize long-term performance.
• Comparing the size of the option grant to similar companies would require further analysis of Curis Inc.'s compensation policies and market capitalization.

Stakeholder Impact

• Shareholders may view the option grant as a way to incentivize the CFO to improve company performance.
• Employees may see the shareholder approval of the stock incentive plan as a positive sign for future equity-based compensation.

Key Dates